Fiberoptic-based sensors have been developed for monitoring human exposure and health effects associated with polycyclic aromatic compounds such as benzo[a]pyrene. These sensors take advantage of the physical properties of optical fibers including their relatively small size, remote sensing capabilities, and their inertness to electrical interferences. the recent development of submicron-sized optical fibers provides an opportunity to further reduce the size of fiberoptic-based sensors for application in submicron environments. This paper describes the development of an antibody based submicron fiber biosensor. the antibody-based biosensor is more selective and sensitive than a nonantibody sensor and has an absolute detection limit of ≈ 300 zeptomoles (10−21 moles) for benzo pyrene tetrol, a product of the benzo[a]pyrene DNA adduct. This submicron-size biosensor could provide a useful tool for measurements of toxic chemicals and related metabolites in sub cellularsize environments.
No takes yet. Share an insight, caveat, or question.
Alarie et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: